
Rohto Pharmaceutical Co Ltd
TSE:4527

Intrinsic Value
The intrinsic value of one
Rohto Pharmaceutical Co Ltd
stock under the Base Case scenario is
3 091.65
JPY.
Compared to the current market price of 2 373.5 JPY,
Rohto Pharmaceutical Co Ltd
is
Undervalued by 23%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Rohto Pharmaceutical Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Rohto Pharmaceutical Co Ltd
Balance Sheet Decomposition
Rohto Pharmaceutical Co Ltd
Current Assets | 205.4B |
Cash & Short-Term Investments | 61.7B |
Receivables | 73.9B |
Other Current Assets | 69.9B |
Non-Current Assets | 198.4B |
Long-Term Investments | 48.1B |
PP&E | 86.8B |
Intangibles | 54.6B |
Other Non-Current Assets | 9B |
Free Cash Flow Analysis
Rohto Pharmaceutical Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Rohto Pharmaceutical Co Ltd
Revenue
|
295.6B
JPY
|
Cost of Revenue
|
-126.7B
JPY
|
Gross Profit
|
168.9B
JPY
|
Operating Expenses
|
-131.8B
JPY
|
Operating Income
|
37.1B
JPY
|
Other Expenses
|
-7.5B
JPY
|
Net Income
|
29.6B
JPY
|
Profitability Score
Profitability Due Diligence
Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.

Score
Rohto Pharmaceutical Co Ltd's profitability score is 58/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Rohto Pharmaceutical Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.

Score
Rohto Pharmaceutical Co Ltd's solvency score is 88/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Rohto Pharmaceutical Co Ltd
According to Wall Street analysts, the average 1-year price target for
Rohto Pharmaceutical Co Ltd
is 3 308.2 JPY
with a low forecast of 1 969.5 JPY and a high forecast of 4 263 JPY.
Dividends
Current shareholder yield for Rohto Pharmaceutical Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Rohto Pharmaceutical Co Ltd
stock under the Base Case scenario is
3 091.65
JPY.
Compared to the current market price of 2 373.5 JPY,
Rohto Pharmaceutical Co Ltd
is
Undervalued by 23%.